NEW YORK (GenomeWeb) – A quantitative nucleic acid amplification test for HIV-1 from Hologic has been granted pre-market approval from the US Food and Drug Administration, the company announced today.

The Aptima HIV-1 Quant test runs on Hologic's fully automated Panther system and amplifies RNA from patient plasma specimens for the purposes of HIV viral load monitoring in the US. Outside the US, it is CE-IVD marked for both diagnosis and monitoring.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.